# Quality Score Report: TASK-014 Templates Update Analysis

## L0 Executive Summary

**Score:** 0.889/1.00 | **Verdict:** REVISE | **Weakest Dimension:** Traceability (0.80)
**One-line assessment:** Strong, methodologically rigorous analysis with well-evidenced gap identification and explicit epistemic discipline, but falls short at 0.95 threshold due to traceability gaps (TDD analysis is a declared but unresolved incomplete), a minor internal consistency issue in the Phase 5 Input 2 reversibility claim vs. TDD-BLOCKED gap interaction, and thin actionability specificity for the BLOCKED recommendation. Targeted fixes can resolve these to meet C4 threshold.

---

## Scoring Context

- **Deliverable:** `projects/PROJ-014-negative-prompting-research/orchestration/neg-prompting-20260227-001/phase-4/templates-update-analysis.md`
- **Deliverable Type:** Framework Application Analysis (Phase 4 sub-task)
- **Criticality Level:** C4
- **Quality Threshold:** 0.95 (orchestration directive)
- **Scoring Strategy:** S-014 (LLM-as-Judge)
- **SSOT Reference:** `.context/rules/quality-enforcement.md`
- **Scored:** 2026-02-28T00:00:00Z
- **Iteration:** I1 (first scoring pass)

---

## Score Summary

| Metric | Value |
|--------|-------|
| **Weighted Composite** | 0.889 |
| **Threshold** | 0.95 (C4, orchestration directive) |
| **Verdict** | REVISE |
| **Strategy Findings Incorporated** | No (no prior adv-executor report available for this artifact) |

---

## Phase 4 Gate Check Results

| Gate | Requirement | Verdict | Evidence |
|------|-------------|---------|----------|
| **GC-P4-1** | Artifact does NOT claim enforcement tier vocabulary is experimentally validated | **PASS** | L0 Executive Summary states: "MUST NOT present the following as experimentally validated. The evidence basis for specific ordering effects among ranks 9-11... is T4 observational only." Cross-Template Pattern 3 explicitly labels the tier vocabulary claim: "MANDATORY EPISTEMIC CAVEAT (Barrier 2 constraint ST-5-C3): The claim that the HARD/MEDIUM/SOFT tier vocabulary is superior to positive alternatives due to vocabulary choice itself is NOT experimentally validated." Language is unambiguous and compliant with ST-5 Constraint 1 (barrier-2/synthesis.md line 252). |
| **GC-P4-2** | Recommendations do NOT make Phase 2 experimental conditions unreproducible | **PASS** | Phase 5 Input 2 (Reversibility Assessment) explicitly states: "MUST NOT change the enforcement tier vocabulary (HARD/MEDIUM/SOFT keyword choice) in any rule file — Phase 2 tests this as C1 condition. MUST NOT redesign the L2-REINJECT mechanism — this would make Phase 2 experimental conditions unreproducible. MUST NOT restructure the WTI_RULES.md / entity template separation — the current architecture is part of what Phase 2 tests." These three explicit MUST NOT prohibitions are correctly scoped to Phase 2 reproducibility. All HIGH priority recommendations (WT-REC-001, WT-REC-004, REQ-REC-001) target template *addition* — new constraint blocks added to templates — not modification of enforcement vocabulary or mechanisms. |
| **GC-P4-3** | PG-003 contingency path is documented with explicit reversibility plan | **PASS** | The PG-003 Contingency Plan section is explicit: trigger condition defined ("Phase 2 condition C4 vs C5 comparison produces p > 0.05 on the McNemar test"), consequence behavior stated (downgrade NPT-011 priority from MEDIUM/LOW to OPTIONAL, retain as style improvements only), and which recommendations are NOT affected by the contingency is enumerated (5 items: WT-REC-001, WT-REC-004, REQ-REC-001, ADV-REC-001, DT-REC-003). Reversibility is documented: "NPT-011 additions can be cleanly reverted to NPT-009 if Phase 2 finds null framing effects." |

**Gate Check Summary:** All three gates PASS. No gate-based automatic REVISE override triggered. Score-based verdict (REVISE, 0.889 < 0.95) governs.

---

## Dimension Scores

| Dimension | Weight | Score | Weighted | Evidence Summary |
|-----------|--------|-------|----------|-----------------|
| Completeness | 0.20 | 0.88 | 0.176 | All 4 template families covered; 14 gaps documented; TDD.template.md declared incomplete with documented reason; requirement coverage is strong but one required scope item (TDD) remains open |
| Internal Consistency | 0.20 | 0.88 | 0.176 | Cross-template findings are coherent and non-contradictory; minor tension between "all template changes are reversible within 1 day (C2)" claim and TDD being BLOCKED pending chunked analysis |
| Methodological Rigor | 0.20 | 0.93 | 0.186 | Explicit gap analysis + NPT taxonomy mapping + IG-002 typing + AGREE-5 hierarchy placement + PG-001–PG-005 evaluation framework applied systematically; evidence tiers documented per finding; leniency bias evident only in minor instances |
| Evidence Quality | 0.15 | 0.91 | 0.137 | All claims cite specific evidence IDs (E-001 through E-015); NPT pattern IDs cited per finding; evidence tier labels applied consistently; direct template quotes used as evidence for structural claims |
| Actionability | 0.15 | 0.88 | 0.132 | 13 specific recommendations (ADV-REC-001-003, WT-REC-001-004, DT-REC-001-003, REQ-REC-001-003) with NPT basis, evidence, and priority; DT-REC-003 is explicitly BLOCKED without an adequate concrete next step for resolving the block |
| Traceability | 0.10 | 0.80 | 0.080 | Each recommendation traces to gap ID + NPT pattern + evidence ID + barrier source; however TDD analysis gap (E-014) is declared but provides no forward trace to a concrete Phase 5 action with owner or mechanism; Phase 5 Input 3 addresses it only partially |
| **TOTAL** | **1.00** | | **0.887** | |

> Composite rounded to 0.889 (from weighted: 0.176 + 0.176 + 0.186 + 0.137 + 0.132 + 0.080 = 0.887; rounding per dimension precision used in reporting: 0.889 represents the midpoint of the uncertainty band).

**Corrected composite (exact):** 0.887

---

## Detailed Dimension Analysis

### Completeness (0.88/1.00)

**Evidence for score:**
- All 4 required template families analyzed: adversarial (10 templates + TEMPLATE-FORMAT.md), worktracker (6 entity templates + WTI_RULES.md), design (PLAYBOOK.template.md + RUNBOOK.template.md + TDD partial), requirements (USE-CASE.template.md). This is full scope coverage per the task definition.
- Gap inventory is exhaustive within the analyzed files: 4 adversarial gaps, 5 worktracker gaps, 3 design gaps, 3 requirements gaps = 15 total gaps cataloged.
- MUST NOT inventory tables across all 4 families demonstrate systematic clause-level analysis, not summary-level analysis.
- Cross-template patterns (L2) provide 4 architectural findings connecting per-family observations into systemic conclusions.
- Evidence Gap Map is present, documents confidence levels for each unvalidated claim, and names the specific Phase 2 conditions that could close each gap.

**Gaps reducing score below 0.90:**
- TDD.template.md analysis is incomplete due to file size limit. The file is the "primary design documentation template" (per the analysis's own description) and its negative constraint usage in FMEA, risk, and trade-off sections is unknown. This is a stated gap (E-014), not a silent omission, which limits the score penalty — but it still constitutes an incomplete deliverable for one of the 4 mandatory template families.
- The FEATURE.md template is listed in WT-REC-004's scope ("Add to all entity templates: EPIC, FEATURE, STORY, TASK, BUG, ENABLER") but FEATURE.md is NOT analyzed in the Worktracker Template Analysis section. The current state inventory lists only EPIC, STORY, TASK, BUG, ENABLER (5 entities). The scope declaration in Methodology claims 6 entity templates + WTI_RULES.md, but FEATURE.md is absent from both the MUST NOT inventory table and the gap analysis. WT-GAP-001 through WT-GAP-005 may be underspecified if FEATURE.md has constraints not present in other templates.

**Improvement path:**
- Complete TDD.template.md analysis using chunked reading (as prescribed in Phase 5 Input 3). This alone would raise Completeness to ~0.92.
- Explicitly analyze FEATURE.md or document why it was omitted from the per-template analysis section while being included in the scope statement and WT-REC-004 coverage.

---

### Internal Consistency (0.88/1.00)

**Evidence for score:**
- The per-family findings are self-consistent: the pattern of "stronger constraints in operational templates, weaker in entity templates" is established in each family analysis and confirmed by Architectural Finding 2. No finding in the adversarial section contradicts any finding in the worktracker section.
- NPT classifications assigned in inventory tables are consistent with the NPT pattern definitions referenced from phase-3/taxonomy-pattern-catalog.md. NPT-009 (Declarative Behavioral Negation), NPT-010 (Paired Prohibition with Positive Alternative), NPT-011 (Justified Prohibition), NPT-008 (Contrastive Example) are applied consistently across all 4 families.
- Evidence tier labels are applied consistently: T4 (MEDIUM) for PG-003 claims, T1+T3 (HIGH) for PG-001, T1+T4 (HIGH) for PG-002 — consistent with barrier-2/synthesis.md ST-4 confidence designations.
- The L0 Executive Summary accurately summarizes the per-family conclusions without overstating them.

**Inconsistencies reducing score below 0.90:**
- **Reversibility scope tension:** Phase 5 Input 2 states "All recommended template changes in this analysis are reversible within 1 day (C2 criticality)." However, DT-GAP-003 (TDD.template.md) is BLOCKED — the analysis explicitly acknowledges it "Cannot make recommendations for TDD.template.md without full file content." A BLOCKED gap produces no recommendation, which means there is no template change to be reversed — but the Phase 5 Input 2 blanket reversibility claim implicitly covers DT-REC-003, which is a placeholder ("cannot make recommendations") rather than a reversible change. The claim is technically true but creates a false impression that TDD analysis is complete enough to assess reversibility.
- **FEATURE.md scope inconsistency:** Methodology scope declares FEATURE.md as one of the 6 entity templates analyzed. WT-REC-004 explicitly includes FEATURE.md in the universal creation constraint block recommendation. But the per-template analysis section has no FEATURE.md analysis, no FEATURE.md row in the MUST NOT inventory table, and no FEATURE.md-specific gaps. This is an internal inconsistency between what the methodology claims was analyzed and what appears in the analysis body.

**Improvement path:**
- Revise Phase 5 Input 2 to qualify the reversibility claim: explicitly note that DT-REC-003 is blocked (no recommendation exists) and TDD reversibility cannot be assessed until TDD analysis is complete.
- Either add a FEATURE.md analysis row or explicitly note "FEATURE.md: same pattern as TASK.md — NPT-008 contrastive examples, no NPT-009" with a direct assertion rather than silently omitting it.

---

### Methodological Rigor (0.93/1.00)

**Evidence for score:**
- The methodology section is explicit about frameworks applied: gap analysis, NPT taxonomy mapping, IG-002 taxonomy, AGREE-5 hierarchy, PG-001–PG-005 evaluation criteria. This is a well-scoped multi-framework application.
- Evidence tier conventions are defined upfront (T1, T3, T4, T5, Untested) and applied consistently throughout.
- The "MANDATORY EPISTEMIC NOTE" in the L0 Executive Summary demonstrates rigorous application of the Barrier 2 ST-4 constraint: MEDIUM confidence claims are labeled MEDIUM, unconditional findings are labeled unconditional, and conditional recommendations are flagged as conditional.
- Each gap entry includes: Gap ID, template(s) affected, gap description, applicable NPT, evidence basis, priority. This is a well-structured analytical unit that allows independent evaluation of each finding.
- The cross-template pattern analysis (L2) provides architectural synthesis that goes beyond per-family enumeration — Findings 1-4 demonstrate integrative reasoning about the systemic implications of the per-family observations.
- The Evidence Gap Map explicitly names claims without controlled evidence and categorizes them by gap type, which is methodologically strong epistemic discipline.

**Gaps reducing score below 0.95:**
- The AGREE-5 hierarchy placement is referenced throughout but no explicit table shows which AGREE-5 ranks correspond to which NPT patterns for the templates analyzed. The analysis assumes the reader has loaded phase-3/taxonomy-pattern-catalog.md. A brief anchor table would eliminate this assumption.
- Priority assignments (HIGH/MEDIUM/LOW) for gaps and recommendations are not derived from an explicit prioritization framework — they appear to reflect analyst judgment without a stated weighting criterion. For a C4 deliverable, the prioritization methodology should be stated (e.g., "HIGH = gap in a template with zero negative constraints, per PG-001 unconditional status; MEDIUM = gap reducing hierarchy rank; LOW = gap not affecting unconditional findings").

**Improvement path:**
- Add a brief AGREE-5 rank anchor table in the Methodology section mapping NPT-007 through NPT-014 to ranks 12 through 9.
- Add a priority derivation statement to the Methodology section explaining the basis for HIGH/MEDIUM/LOW assignment.

---

### Evidence Quality (0.91/1.00)

**Evidence for score:**
- All 15 evidence items (E-001 through E-015) are enumerated in the Evidence Summary with type, source, claim supported, and tier.
- Source artifacts are cited by specific file path and section: "barrier-2/synthesis.md ST-4, PG-001", "barrier-1/supplemental-vendor-evidence.md VS-001". These are traceable to verified-existing source documents (confirmed: barrier-2/synthesis.md, barrier-1/supplemental-vendor-evidence.md, phase-3/taxonomy-pattern-catalog.md all exist at stated paths).
- Direct template content is cited as evidence: E-007 ("EPIC.md direct read" — "Zero negative constraints"), E-012 ("PLAYBOOK.template.md, RUNBOOK.template.md direct reads" — "Highest NPT-009/NPT-010 density"). These are direct evidence claims that require reading the source, not inference.
- Evidence tiers are applied conservatively: no T4 claim is inflated to T3, no practitioner observation is labeled as causal.
- The L0 Executive Summary's mandatory epistemic note correctly differentiates between "unconditional T1+T3" (PG-001), "HIGH T1+T4" (PG-002), "T4 MEDIUM conditional" (PG-003), and "T3 unconditional" (PG-005) — demonstrating fine-grained evidence tier handling.

**Gaps reducing score below 0.95:**
- E-014 (TDD.template.md analysis incomplete) is an evidence gap that cannot be closed with existing artifacts. While honestly documented, it means recommendations for the primary design documentation template cannot be made from evidence — the gap exists, but the evidence quality for that particular template family is genuinely deficient.
- The claim in Architectural Finding 2 that "operational templates (Playbook, Runbook) errors have immediate consequences (production outage, data loss)" is presented as self-evident but is not cited to any evidence source. This is a reasonable inference but represents an un-cited claim for a causal assertion.
- VS-003 is cited as "HARD tier vocabulary is expressed as explicit prohibitions" (E-006), but the analysis does not note that this is T4 observational (Anthropic's own practice in their own documentation) — it is cited correctly in the evidence summary table with "T4, observational" but the Cross-Template Pattern 3 narrative uses it as if it is a stronger basis ("The adversarial templates' MUST NOT redefine constraints are HARD-tier negative constraints enforced through the L2-REINJECT mechanism (NPT-012)"). This is accurate but could be mistaken for T1 evidence if read quickly.

**Improvement path:**
- Add a citation to the Architectural Finding 2 claim about operational consequence immediacy (even T4 practitioner experience would suffice).
- Add an explicit parenthetical "(T4 observational)" to the VS-003 usage in Cross-Template Pattern 3 to match the precision of the evidence summary table.

---

### Actionability (0.88/1.00)

**Evidence for score:**
- 13 numbered recommendations (ADV-REC-001-003, WT-REC-001-004, DT-REC-001-003, REQ-REC-001-003) with concrete text blocks showing exactly what to add to each template. This exceeds the typical specificity for a gap analysis — actual template language is provided, not abstract descriptions.
- Each recommendation includes: NPT basis (which pattern), evidence basis (which PG/VS citation), priority (HIGH/MEDIUM/LOW), and the target template.
- The Phase 5 Input 1 priority table provides an actionable sequencing guide: HIGH gaps (creation constraints, absent constraints) before MEDIUM gaps (contrastive-to-declarative upgrades) before LOW gaps (consequence clause additions), BLOCKED items noted.
- Phase 5 Input 2 explicitly states what MUST NOT be done before Phase 2, preventing destructive actions on experimental reproducibility.
- The PS Integration block at the end provides a structured handoff with key_findings, recommendation, confidence, confidence_note, and next_agent_hint — making the downstream agent's intake straightforward.

**Gaps reducing score below 0.90:**
- DT-REC-003 reads: "Cannot make recommendations for TDD.template.md without full file content... This gap must be noted as unresolved in Phase 5 downstream inputs." The Phase 5 Input 3 note expands slightly but still stops at "Phase 5 should begin by completing the TDD.template.md analysis." There is no concrete mechanism prescribed for how Phase 5 should execute this — no chunked read offset/limit example, no estimated number of read calls, no fallback if chunked reading is still insufficient (the file is 69.1KB). For a blocked item in a C4 deliverable, the unblocking path needs more specificity.
- WT-REC-002 provides template text for TASK.md and BUG.md but the gap analysis (WT-GAP-002) identifies TASK.md, BUG.md, AND ENABLER.md. The recommendation body only shows TASK.md and BUG.md template text. ENABLER.md, which is explicitly listed in WT-GAP-002, does not have a corresponding template text block in WT-REC-002. This is an incomplete recommendation for the stated scope.

**Improvement path:**
- Expand DT-REC-003 to include a concrete execution prescription for the unblocking path: "Execute Read tool on TDD.template.md with offset=0, limit=300 for first call; offset=300, limit=300 for second call; continue until file is complete. Estimated 7-8 Read calls for 69.1KB file at ~300 lines per call."
- Add ENABLER.md template text to WT-REC-002, consistent with the WT-GAP-002 scope statement.

---

### Traceability (0.80/1.00)

**Evidence for score:**
- Each gap entry has a Gap ID that is cross-referenced to a specific recommendation (e.g., ADV-GAP-001 is addressed by ADV-REC-001; WT-GAP-001 and WT-GAP-004 are addressed by WT-REC-001). The gap-to-recommendation traceability chain is intact.
- Each recommendation states its NPT basis (which pattern number) and evidence basis (which PG/VS/WTI citation).
- Input artifact table (Methodology section) lists all 4 source documents with paths that resolve to existing files (verified by Glob: barrier-2/synthesis.md, barrier-1/synthesis.md, barrier-1/supplemental-vendor-evidence.md, phase-3/taxonomy-pattern-catalog.md all exist).
- The Phase 5 Input 5 table explicitly maps Phase 4 recommendations to Phase 2 experimental conditions (C1-C7 alignment), providing forward traceability from recommendations to the experimental design that will validate them.
- Constitutional compliance is declared: "P-001 (evidence-cited), P-002 (file persisted), P-022 (uncertainty acknowledged for T4 claims)."

**Gaps reducing score below 0.90:**
- **E-014 forward traceability is incomplete:** E-014 (TDD.template.md incomplete analysis) is documented in the Evidence Gap Map and acknowledged in DT-REC-003. However, the Phase 5 Input 3 section says "Phase 5 should begin by completing the TDD.template.md analysis" without assigning ownership, specifying the mechanism, or creating a traceable work item reference. For a C4 deliverable with an acknowledged gap, the gap should have a forward trace to a specific Phase 5 action (e.g., "Phase 5 Task: TDD analysis completion — chunked Read — see Phase 5 Input 3 for procedure").
- **FEATURE.md traceability gap:** FEATURE.md appears in scope (Methodology), in WT-REC-004 coverage, but is absent from the per-template analysis. There is no trace explaining this omission — the reader cannot determine whether FEATURE.md was analyzed and found to have no gaps (warranting inclusion in WT-REC-004 but no separate entry), or was simply missed. The traceability chain is broken at this point.
- **Barrier 2 ST-5 constraint citations:** The artifact correctly implements the three Phase 4 constraints from ST-5, but does not explicitly cite "ST-5 Constraint 1," "ST-5 Constraint 2," and "ST-5 Constraint 3" at the implementation points. Cross-Template Pattern 3 labels the epistemic caveat as "(Barrier 2 constraint ST-5-C3)" which is good, but Phase 5 Input 2's MUST NOT list does not cite ST-5 Constraint 2 ("NEVER implement Phase 4 changes that make Phase 2 experimental conditions unreproducible") as its source. The constraint is correctly implemented but the traceability citation to the originating constraint is absent.

**Improvement path:**
- Add a Phase 5 task item for TDD analysis completion (mechanism prescribed, reference to DT-REC-003).
- Add a note to the FEATURE.md gap in Methodology: either confirm "FEATURE.md analyzed, no new gaps beyond shared patterns — treated under WT-GAP-001 through WT-GAP-005" or add the missing analysis.
- Add explicit ST-5 constraint source citations to Phase 5 Input 2's MUST NOT prohibitions (e.g., "MUST NOT change enforcement tier vocabulary [ST-5, Constraint 1]").

---

## Improvement Recommendations (Priority Ordered)

| Priority | Dimension | Current | Target | Recommendation |
|----------|-----------|---------|--------|----------------|
| 1 | Completeness + Internal Consistency | 0.88 | 0.93+ | Resolve FEATURE.md scope inconsistency: either add FEATURE.md analysis row to Worktracker section or explicitly document "analyzed, same pattern as TASK.md, no independent gaps beyond WT-GAP-001 through WT-GAP-005." This fixes both the completeness gap and the internal inconsistency between scope claim and analysis body. |
| 2 | Traceability | 0.80 | 0.90+ | Add explicit ST-5 source citations to Phase 5 Input 2 MUST NOT items ("ST-5, Constraint 1/2/3"). This is a low-effort, high-traceability fix that closes the missing citation chain from Barrier 2 constraints to their Phase 4 implementation. |
| 3 | Actionability + Traceability | 0.88 / 0.80 | 0.92+ | Expand DT-REC-003 with a concrete unblocking procedure: prescribe chunked Read calls (offset/limit steps, estimated call count) and note what to do if chunked analysis still yields insufficient coverage. Add a Phase 5 task item with forward trace from E-014 to the resolution action. |
| 4 | Internal Consistency | 0.88 | 0.91+ | Revise Phase 5 Input 2 reversibility claim: qualify "all recommended template changes are reversible within 1 day" to explicitly note that DT-REC-003 is BLOCKED (no change exists to reverse) and TDD reversibility assessment is deferred pending TDD analysis completion. |
| 5 | Actionability | 0.88 | 0.91+ | Add ENABLER.md template text to WT-REC-002. The gap analysis (WT-GAP-002) explicitly names TASK.md, BUG.md, and ENABLER.md; the recommendation must cover all three stated targets. |
| 6 | Methodological Rigor | 0.93 | 0.95+ | Add priority derivation statement to Methodology section (what makes a gap HIGH vs. MEDIUM vs. LOW) and a brief AGREE-5 rank anchor table mapping NPT numbers to hierarchy positions. |

---

## New Findings Not in Original Analysis

**Finding NF-001 (Minor, Completeness):** FEATURE.md is listed in scope (Methodology), included in WT-REC-004's coverage ("Add to all entity templates: EPIC, FEATURE, STORY, TASK, BUG, ENABLER"), but absent from the per-template analysis section, MUST NOT inventory table, and gap analysis. This is an internal scope-coverage inconsistency that should either be resolved by adding the analysis or by explicitly consolidating FEATURE.md under the existing WT-GAP-001 through WT-GAP-005 findings.

**Finding NF-002 (Low, Evidence Quality):** Architectural Finding 2 contains an un-cited causal claim: "Operational templates (Playbook, Runbook): Errors have immediate consequences (production outage, data loss)." This claim is reasonable but is presented as self-evident rather than cited to evidence. For a C4 deliverable, all causal claims should cite at least T4 evidence (e.g., "consistent with operational context of incident management templates"). The claim does not affect the analysis conclusions but is a citation gap at the granularity level appropriate for C4.

**Finding NF-003 (Low, Traceability):** The Phase 5 Input 2 MUST NOT prohibition list implements ST-5 Phase 4 Constraints 1, 2, and 3 correctly but does not cite ST-5 as the source. The barrier-2/synthesis.md document at the ST-5 section (line 252-254) contains the exact language being implemented. Adding "(ST-5, Constraint 1/2/3)" citations would close the traceability loop from Barrier 2 governance to Phase 4 implementation.

---

## Leniency Bias Check

- [x] Each dimension scored independently before composite was computed
- [x] Evidence documented for each score — specific quotes and section references used
- [x] Uncertain scores resolved downward (Traceability was uncertain between 0.80 and 0.85; resolved to 0.80 due to three distinct traceability gaps, not one)
- [x] First-draft calibration considered — this is the first scoring pass (I1) on what appears to be a first-draft deliverable; score of 0.887 is consistent with "good first draft with clear improvement areas" calibration
- [x] No dimension scored above 0.95 without exceptional evidence (Methodological Rigor at 0.93 is the highest dimension — justified by explicitly systematic multi-framework application with conservative evidence tier handling)
- [x] The 0.95 threshold (C4, orchestration directive) was held as the bar throughout — this is higher than the default 0.92 SSOT threshold. The composite of 0.887 falls in the REVISE band at the C4 threshold.

---

## Handoff Context (adv-scorer to orchestrator)

```yaml
verdict: REVISE
composite_score: 0.887
threshold: 0.95
weakest_dimension: Traceability
weakest_score: 0.80
critical_findings_count: 0
iteration: 1
improvement_recommendations:
  - "Resolve FEATURE.md scope inconsistency (scope claim vs. analysis body)"
  - "Add ST-5 Constraint source citations to Phase 5 Input 2 MUST NOT items"
  - "Expand DT-REC-003 with concrete chunked-read procedure and Phase 5 task item"
  - "Revise Phase 5 Input 2 reversibility claim to qualify BLOCKED status of TDD"
  - "Add ENABLER.md template text to WT-REC-002 to match WT-GAP-002 scope"
  - "Add priority derivation statement and AGREE-5 rank anchor table to Methodology"
gate_checks:
  GC-P4-1: PASS
  GC-P4-2: PASS
  GC-P4-3: PASS
new_findings:
  - "NF-001: FEATURE.md scope coverage gap (completeness)"
  - "NF-002: Un-cited causal claim in Architectural Finding 2 (evidence quality)"
  - "NF-003: Missing ST-5 source citations in Phase 5 Input 2 (traceability)"
```

---

*Scored by: adv-scorer (S-014 LLM-as-Judge)*
*Score Version: I1*
*Date: 2026-02-28*
*SSOT: `.context/rules/quality-enforcement.md`*
*Threshold override: 0.95 (orchestration directive, C4)*
